Kaitlyn D’Onofrio

DocwireNews

Patients with uterine serous carcinoma are at an increased risk of developing venous&nbsp;thromboembolism&nbsp;(VTE)&nbsp;not just immediately following operation but months after surgery,&nbsp;according to a recent study.&nbsp;Researchers retrospectively assessed 413 women diagnosed with uterine serous carcinoma between 1999 and 2016 at a single institution; 70 patients (17%) developed VTE after a median of 7.2 months from presentation to VTE and 13.2 months from surgery to VTE. Of the 70 VTE patients, 59 (84%) were diagnosed either before surgery or more than six weeks following surgery, and 22 (31%) were on chemotherapy when they were diagnosed. Median Khorana score for patients diagnosed while on chemotherapy was one;&nbsp;pharmacologic prophylaxis&nbsp;is recommended in patients with a score of three or higher. Cancer stages III (hazard ratio [HR] 3.20, 95% CI 1.54&ndash;6.64) and IV (HR 8.68, 95% CI 4.50&ndash;16.73) and hypertensive&nbsp;(HR 2.29, 95% CI 1.08&ndash;4.85) or cardiovascular diseases (HR 1.82, 95% CI 1.05&ndash;3.13) were associated with time&nbsp;to VTE.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<a href="https://twitter.com/hashtag/Venous?src=hash&amp;ref_src=twsrc%5Etfw">#Venous</a> <a href="https://twitter.com/hashtag/Thromboembolism?src=hash&amp;ref_src=twsrc%5Etfw">#Thromboembolism</a> in Cancer: Earn credits &amp; learn about current and emerging approaches to primary prevention and how to treat VTE in patients with cancer. &ndash; with Drs. Jeffrey I. Weitz of <a href="https://twitter.com/machealthsci?ref_src=twsrc%5Etfw">@MacHealthSci</a> &amp; <a href="https://twitter.com/aakonc?ref_src=twsrc%5Etfw">@aakonc</a> of <a href="https://twitter.com/ClevelandClinic?ref_src=twsrc%5Etfw">@ClevelandClinic</a> <a href="https://t.co/sl6yJFLNyZ">https://t.co/sl6yJFLNyZ</a> <a href="https://t.co/RYPG6SLArV">pic.twitter.com/RYPG6SLArV</a>
&mdash; Medscape Education (@MedscapeCME) <a href="https://twitter.com/MedscapeCME/status/1054539661840932864?ref_src=twsrc%5Etfw">October 23, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&ldquo;Although this is a retrospective study, it generates the hypothesis that venous thromboembolism prophylaxis may be beneficial in women with active uterine serous carcinoma, at least while receiving treatment such as neoadjuvant or adjuvant chemotherapy,&rdquo;&nbsp;the study authors wrote.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Easy listening for this weekend-<a href="https://twitter.com/JAMA_current?ref_src=twsrc%5Etfw">@JAMA_current</a> Clinical Reviews <a href="https://twitter.com/hashtag/podcast?src=hash&amp;ref_src=twsrc%5Etfw">#podcast</a> on Venous Thromboembolic Disease &ndash; interview with Dr. Phil Wells from <a href="https://twitter.com/uOttawaMed?ref_src=twsrc%5Etfw">@uOttawaMed</a> get <a href="https://twitter.com/hashtag/CME?src=hash&amp;ref_src=twsrc%5Etfw">#CME</a> <a href="https://twitter.com/hashtag/FOAMed?src=hash&amp;ref_src=twsrc%5Etfw">#FOAMed</a> <a href="https://t.co/7pRQU9lbCW">pic.twitter.com/7pRQU9lbCW</a>
&mdash; Ed Livingston (@ehlJAMA) <a href="https://twitter.com/ehlJAMA/status/1056188902422335489?ref_src=twsrc%5Etfw">October 27, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&ldquo;Ours is not the first report to posit that currently available venous thromboembolism risk stratification tools are of limited utility in gynecologic oncology patients,&rdquo;&nbsp;they added.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Advances in Diagnosis and Treatment of Venous Thromboembolism <a href="https://t.co/KeqTmyqdiX">https://t.co/KeqTmyqdiX</a>
&mdash; EMAS (@emas_online) <a href="https://twitter.com/emas_online/status/1056595597103427585?ref_src=twsrc%5Etfw">October 28, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>The researchers called for larger prospective studies to confirm the benefits of VTE prophylaxis while cancer patients are actively being treated.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
What advances have occurred in venous thromboembolism (VTE) diagnosis and management over the past 5 years? <a href="https://t.co/eM4XIq9Lkc">https://t.co/eM4XIq9Lkc</a> <a href="https://twitter.com/hashtag/VTE?src=hash&amp;ref_src=twsrc%5Etfw">#VTE</a> <a href="https://twitter.com/hashtag/cardiology?src=hash&amp;ref_src=twsrc%5Etfw">#cardiology</a> <a href="https://twitter.com/ACCinTouch?ref_src=twsrc%5Etfw">@ACCinTouch</a> <a href="https://t.co/tRgsHGxeZt">pic.twitter.com/tRgsHGxeZt</a>
&mdash; Arie Blitz, MD, MBA (@ArieBlitzMD) <a href="https://twitter.com/ArieBlitzMD/status/1055096640154013697?ref_src=twsrc%5Etfw">October 24, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><a href="https://proddocwire.wpengine.com/abstracts/long-term-risk-of-venous-thromboembolism-in-survivors-of-childhood-cancer-a-report-from-the-childhood-cancer-survivor-study/">Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report&nbsp;From&nbsp;the Childhood Cancer Survivor Study.</a>&nbsp;<a href="https://proddocwire.wpengine.com/abstracts/venous-thromboembolism-patients/">Venous Thromboembolism in Patients with Sarcoma: A Retrospective Study</a>&nbsp;<a href="https://proddocwire.wpengine.com/abstracts/aspirin-venous-thromboembolism-patients/">Association of Aspirin&nbsp;With&nbsp;Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty Compared With Other Anticoagulants: A Noninferiority Analysis</a>&nbsp;<a href="https://proddocwire.wpengine.com/abstracts/pulmonary-embolism-severity-index/">Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry</a>&nbsp;Sources:&nbsp;<a href="https://www.mdedge.com/oncologypractice/article/177912/gynecologic-cancer/vte-risk-may-be-high-throughout-disease-course">Oncology Practice</a>,&nbsp;<a href="https://insights.ovid.com/crossref?an=00006250-201811000-00007">Obstetrics &amp; Gynecology</a>

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Uterine Serous Carcinoma Patients Have Long Risk of VTE

Patients with uterine serous carcinoma are at an increased risk of developing venous thromboembolism (VTE) not just immediately following operation but months after ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe